ψ p-value < 0.05
*First choice induction method: In August 2017, 7/50 (14%) were induced
by artificial rupture of membranes, 24/50 (48%) by misoprostol and
19/50 (38%) by oxytocin. In November 2017, 17/74 (23%) were induced by
artificial rupture of membranes, 35/74 (47%) by misoprostol and 22/74
(30%) by oxytocin. The most common indications for induction were
pre-eclampsia, pre-labour rupture of membranes and postterm, and
there were no significant differences in the frequencies of indications
in the months studied (p=0.63).
**In 6/108 (6%) and 4/82 (5%), respectively, caesarean section was
performed after diagnosed intrauterine foetal death.
***In 26/220 (12%) and 19/193 (10%), respectively, oxytocin
augmentation was initiated before crossing the action line.
****In 19/30 (63%) and 19/23 (83%), respectively, the action line was
either not yet crossed or the partograph unused when deciding on
caesarean section due to prolonged labour, and in 16/30 (53%) and 7/23
(30%) oxytocin augmentation had not been tried.
*****In 6/12 (50%) and 6/13 (46%), respectively, last FHR was recorded
in the normal range (110-160 bpm).
******Other indications for caesarean sections placenta previa, severe
antepartum haemorrhage, cord prolapse, rupture of uterus, reduced foetal
movement, unclear indications
|
ψ p-value < 0.05
*First choice induction method: In August 2017, 7/50 (14%) were induced
by artificial rupture of membranes, 24/50 (48%) by misoprostol and
19/50 (38%) by oxytocin. In November 2017, 17/74 (23%) were induced by
artificial rupture of membranes, 35/74 (47%) by misoprostol and 22/74
(30%) by oxytocin. The most common indications for induction were
pre-eclampsia, pre-labour rupture of membranes and postterm, and
there were no significant differences in the frequencies of indications
in the months studied (p=0.63).
**In 6/108 (6%) and 4/82 (5%), respectively, caesarean section was
performed after diagnosed intrauterine foetal death.
***In 26/220 (12%) and 19/193 (10%), respectively, oxytocin
augmentation was initiated before crossing the action line.
****In 19/30 (63%) and 19/23 (83%), respectively, the action line was
either not yet crossed or the partograph unused when deciding on
caesarean section due to prolonged labour, and in 16/30 (53%) and 7/23
(30%) oxytocin augmentation had not been tried.
*****In 6/12 (50%) and 6/13 (46%), respectively, last FHR was recorded
in the normal range (110-160 bpm).
******Other indications for caesarean sections placenta previa, severe
antepartum haemorrhage, cord prolapse, rupture of uterus, reduced foetal
movement, unclear indications
|
ψ p-value < 0.05
*First choice induction method: In August 2017, 7/50 (14%) were induced
by artificial rupture of membranes, 24/50 (48%) by misoprostol and
19/50 (38%) by oxytocin. In November 2017, 17/74 (23%) were induced by
artificial rupture of membranes, 35/74 (47%) by misoprostol and 22/74
(30%) by oxytocin. The most common indications for induction were
pre-eclampsia, pre-labour rupture of membranes and postterm, and
there were no significant differences in the frequencies of indications
in the months studied (p=0.63).
**In 6/108 (6%) and 4/82 (5%), respectively, caesarean section was
performed after diagnosed intrauterine foetal death.
***In 26/220 (12%) and 19/193 (10%), respectively, oxytocin
augmentation was initiated before crossing the action line.
****In 19/30 (63%) and 19/23 (83%), respectively, the action line was
either not yet crossed or the partograph unused when deciding on
caesarean section due to prolonged labour, and in 16/30 (53%) and 7/23
(30%) oxytocin augmentation had not been tried.
*****In 6/12 (50%) and 6/13 (46%), respectively, last FHR was recorded
in the normal range (110-160 bpm).
******Other indications for caesarean sections placenta previa, severe
antepartum haemorrhage, cord prolapse, rupture of uterus, reduced foetal
movement, unclear indications
|
ψ p-value < 0.05
*First choice induction method: In August 2017, 7/50 (14%) were induced
by artificial rupture of membranes, 24/50 (48%) by misoprostol and
19/50 (38%) by oxytocin. In November 2017, 17/74 (23%) were induced by
artificial rupture of membranes, 35/74 (47%) by misoprostol and 22/74
(30%) by oxytocin. The most common indications for induction were
pre-eclampsia, pre-labour rupture of membranes and postterm, and
there were no significant differences in the frequencies of indications
in the months studied (p=0.63).
**In 6/108 (6%) and 4/82 (5%), respectively, caesarean section was
performed after diagnosed intrauterine foetal death.
***In 26/220 (12%) and 19/193 (10%), respectively, oxytocin
augmentation was initiated before crossing the action line.
****In 19/30 (63%) and 19/23 (83%), respectively, the action line was
either not yet crossed or the partograph unused when deciding on
caesarean section due to prolonged labour, and in 16/30 (53%) and 7/23
(30%) oxytocin augmentation had not been tried.
*****In 6/12 (50%) and 6/13 (46%), respectively, last FHR was recorded
in the normal range (110-160 bpm).
******Other indications for caesarean sections placenta previa, severe
antepartum haemorrhage, cord prolapse, rupture of uterus, reduced foetal
movement, unclear indications
|